LINQ II Insertable Cardiac Monitor vs Fetal EchoScan
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A, the Medtronic LINQ II, is an insertable cardiac monitor providing long-term, continuous heart rhythm monitoring for diagnosing arrhythmias in patients aged 2 and older. In contrast, Tool B, Brightheart's Fetal EchoScan, is an AI-powered software that assists clinicians in the prenatal detection of congenital heart defects during ultrasound screenings. While both utilize AI within cardiology, they target different patient populations and diagnostic stages, making them adjacent rather than direct competitors.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
The Medtronic LINQ II is an insertable cardiac monitor for long-term, continuous heart rhythm monitoring, integrating with remote programming and patient-operated data transmission via a mobile app or home communicator. It is ideal for diagnosing arrhythmias in patients with infrequent symptoms. Brightheart's Fetal EchoScan is a software-only device that integrates seamlessly with existing ultrasound machines and reporting solutions, providing real-time AI guidance during prenatal scans to ensure exam completeness and aid in congenital heart defect detection.
The LINQ II utilizes AccuRhythm AI algorithms, which have demonstrated significant reductions in false atrial fibrillation (AF) and pause alerts (e.g., 88.2% reduction in false AF alerts and 97.4% reduction in false pause alerts while preserving 99% and 100% of true alerts, respectively). Fetal EchoScan's AI software has shown high accuracy in detecting suspicious findings associated with severe congenital heart defects, with a sensitivity of 98.7% and specificity of 97.7% in conclusive cases.
The LINQ II offers data export capabilities, and its data flows into the CareLinku2122 network, implying integration for data transfer to support patient management. Fetal EchoScan emphasizes seamless integration with existing ultrasound machines and reporting solutions, being DICOM compatible, which facilitates efficient data flow and structured reporting within existing systems.
For LINQ II, Medtronic provides extensive training resources through Medtronic Academy, including courses, videos, and quizzes for both device insertion and follow-up, covering aspects like remote programming and CareLink Network management. Fetal EchoScan is designed to integrate without disrupting existing workflows and provides real-time guidance during scans, suggesting a supportive learning environment for sonographers and clinicians, with the company aiming to make expert-level screening accessible.
The LINQ II is targeted for deployment from solo practices to large health systems, indicating Medtronic has established processes for scalable deployment of its insertable devices and associated remote monitoring infrastructure. Fetal EchoScan, as a cloud-based software-only device that integrates with existing ultrasound machines, is designed for connected care at scale and aims for streamlined multi-site rollouts with less hardware dependency.
More Comparisons
Backers
Who funded each tool's parent company.